Drug interactions
Dabrafenib + Metformin-pioglitazone
Severity: Moderate
Dabrafenib and Metformin-pioglitazone: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dabrafenib can cause hyperglycemia, and glucose control may worsen in diabetic patients. Labeling advises glucose monitoring in those with diabetes.
What this interaction means in plain words
Dabrafenib and Metformin-pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dabrafenib belongs to Oncology; Metformin-pioglitazone belongs to Endocrine.
Why it happens
Dabrafenib-associated hyperglycemia opposes antidiabetic effect; the mechanism is not clearly established.
What to do
Monitor serum glucose when starting dabrafenib and adjust antidiabetic therapy as needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dabrafenib and Metformin-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Metformin-pioglitazone
Other interactions of Dabrafenib
Frequently asked questions
Can I take Dabrafenib with Metformin-pioglitazone?
MediHelp rates the interaction as moderate. Dabrafenib and Metformin-pioglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dabrafenib can cause hyperglycemia, and glucose control may worsen in diabetic patients. Labeling advises glucose monitoring in those with diabetes.
How serious is the interaction between Dabrafenib and Metformin-pioglitazone?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum glucose when starting dabrafenib and adjust antidiabetic therapy as needed.
What other medicines interact with Metformin-pioglitazone?
MediHelp also lists interactions of Metformin-pioglitazone with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Metformin-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
